Evotec - Research never stops
  • Loading...

Jingxin Pharma: EVT 201

GABAA Receptor Partial Positive Allosteric Modulator- Insomnia

EVT 201 has shown positive results in two Phase II proof of concept trials in both adult and elderly insomnia patients.

Evotec licenses EVT 201 to Jingxin Pharma (see press release)